Mayo Clinic is a leading center for research on celiac disease. Mayo researchers are working to improve methods of diagnosis and treatment. These include the role of genetics in predicting celiac disease, environmental factors that can trigger the disease, new treatments for refractory celiac disease, the development of animal models, and the skin rash associated with celiac disease (dermatitis herpetiformis).

Researchers in the Department of Gastroenterology, in collaboration with the Department of Immunology, are exploring the role of the immune system in celiac disease, as well as the role of the microbiome and our bacterial environment. They also are examining triggers for celiac disease. The intent is to identify the factors that have led to the dramatic increase in celiac disease and, if these are environmental, to see if they can be altered.

Researchers are engaged in clinical trials to address novel therapies for both celiac disease and refractory celiac disease.

Researchers in gastroenterology work together with others in dermatology, immunology, pathology, pediatrics, epidemiology and biostatistics, as well as the Mayo Comprehensive Clinical Cancer Center and the Center for Cell Signaling in Gastroenterology.


See a list of publications by Mayo Clinic doctors on celiac disease on PubMed, a service of the National Library of Medicine.